CVS pushes into making cheaper versions of complex drugs with new discount Humira
CVS Health is partnering with Sandoz to produce a cheaper version of the arthritis drug Humira, as part of its venture into the biosimilars market.
Topics
Posted 8/23/2023, 8:15:52 PM
cnbc.com
Relevant topic timeline:
CVS Health has launched Cordavis, a subsidiary focused on bringing high-quality biosimilar products to the market to reduce drug costs and ensure access to affordable medications in the United States, with plans to develop a portfolio of biosimilar products and partner with Sandoz to commercialize lower-priced biosimilars.
CVS will begin selling cheaper biosimilar versions of prescription medications, starting with its own version of Humira, aiming to drive down the cost of biologic drugs and encourage investment in them.
Novartis' generics drugs unit Sandoz plans to launch five additional biologic drugs as it aims to enhance its investor appeal ahead of its market debut next month, with the goal of becoming the world's largest maker of biosimilars and dethroning Pfizer.